Market Value524,678,504
Total Holdings67
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ELVN / Enliven Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
JAZZ / Jazz Pharmaceuticals plc
BEAM / Beam Therapeutics Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
BPMC / Blueprint Medicines Corporation
DYN / Dyne Therapeutics, Inc.
DXCM / DexCom, Inc.
BLUE / bluebird bio, Inc.
HQY / HealthEquity, Inc.
COR / Cencora, Inc.
UNH / UnitedHealth Group Incorporated
INSM / Insmed Incorporated
PHAT / Phathom Pharmaceuticals, Inc.
CNTX / Context Therapeutics Inc.
TMO / Thermo Fisher Scientific Inc.
QURE / uniQure N.V.
XENE / Xenon Pharmaceuticals Inc.
BSX / Boston Scientific Corporation
DHR / Danaher Corporation
TMDX / TransMedics Group, Inc.
COGT / Cogent Biosciences, Inc.
SGRY / Surgery Partners, Inc.
KPTI / Karyopharm Therapeutics Inc.
BMY / Bristol-Myers Squibb Company
HYPR / Hyperfine, Inc.
LXEO / Lexeo Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
OGN / Organon & Co.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ORIC / ORIC Pharmaceuticals, Inc.
ABBV / AbbVie Inc.
KROS / Keros Therapeutics, Inc.
ISRG / Intuitive Surgical, Inc.
KYMR / Kymera Therapeutics, Inc.
ACHC / Acadia Healthcare Company, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
INCY / Incyte Corporation
ITCI / Intra-Cellular Therapies, Inc.
ILMN / Illumina, Inc.
NMRA / Neumora Therapeutics, Inc. Call
VERA / Vera Therapeutics, Inc.
GKOS / Glaukos Corporation
PCVX / Vaxcyte, Inc.
IONS / Ionis Pharmaceuticals, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
AVTR / Avantor, Inc.
AKRO / Akero Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
BRKR / Bruker Corporation
ACAD / ACADIA Pharmaceuticals Inc.
NBIX / Neurocrine Biosciences, Inc.
CATX / Perspective Therapeutics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
ARVN / Arvinas, Inc. Call
UTHR / United Therapeutics Corporation
IDYA / IDEAYA Biosciences, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
SLNO / Soleno Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc. Call
CGON / CG Oncology, Inc.
ARVN / Arvinas, Inc.
THC / Tenet Healthcare Corporation
DNTH / Dianthus Therapeutics, Inc.
KZR / Kezar Life Sciences, Inc.
ORKA / Oruka Therapeutics, Inc.
EXAS / Exact Sciences Corporation
DOCS / Doximity, Inc.
RVMD / Revolution Medicines, Inc.
HUM / Humana Inc.
HUM / Humana Inc. Call
AXSM / Axsome Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
NTRA / Natera, Inc.
KPTI / Karyopharm Therapeutics Inc.
RGNX / REGENXBIO Inc.
GMAB / Genmab A/S - Depositary Receipt (Common Stock) Call
RPRX / Royalty Pharma plc
IMUX / Immunic, Inc.
BHVN / Biohaven Ltd.
MIRM / Mirum Pharmaceuticals, Inc.
RVPH / Reviva Pharmaceuticals Holdings, Inc.
CAPR / Capricor Therapeutics, Inc.
AGL / agilon health, inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)